ReviewCellular and molecular life sciences : CMLS2026
The crosstalk between lymphatic endothelial cells and immune cells in Physiological and Pathological conditions.
Review in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The lymphatic system serves two primary functions: the absorption of interstitial fluid and the coordination of immune cell interactions and transport. Central to these roles is the dynamic interplay between lymphatic endothelial cells (LECs) and immune cells, which acts as a critical hub for maintaining physiological homeostasis and regulating pathological processes. Under physiological conditions, LECs orchestrate immune responses by establishing chemokine gradients, modulating the metabolic microenvironment, and expressing adhesion molecules. They collaborate with dendritic cells (DCs) to initiate immunity, finely regulate the differentiation and homing of T cell subsets, support B cell-mediated humoral immunity, and work with macrophages to maintain tissue homeostasis. In pathological states, LECs assume a dual role. In inflammatory diseases, such as infections and autoimmune disorders, they recruit immune cells through the secretion of pro-inflammatory cytokines to clear pathogens; conversely, their aberrant antigen presentation may break immune tolerance and promote the activation of autoreactive T and B cells. During cancer progression, tumor-associated LECs adopt context-dependent programs, either constructing immunosuppressive networks that facilitate immune evasion, lymphatic metastasis and resistance to immunotherapy, or supporting antigen transport and presentation that promote antitumor immunity. This review systematically elucidates the molecular mechanisms and translational implications of the interactions between LECs and immune cells. It provides a theoretical foundation for precision therapies targeting the lymphatic-immune network. The insights garnered not only enhance our understanding of the mechanisms underlying disease pathogenesis but also unveil novel therapeutic avenues for targeting inflammatory diseases and cancer, holding significant value for both basic research and clinical translation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.